Oxford Biomedica PLC ORD 50P
Oxford Biomedica PLC ORD 50P/ GB00BDFBVT43 /
OXB
2024-05-02 2:00:59 PM
|
Chg.
+11.7300
|
Volume |
Bid2024-05-02 |
Ask2024-05-02 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
298.7300GBX
|
+4.09%
|
125,057 Turnover(GBP): 363,598.5616 |
296.5000Bid Size: 2,515 |
299.0000Ask Size: 906 |
238.49 mill.GBP |
- |
- |
Fundamentals
|
FY 2020 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
0.08 GBP |
-64.98 |
EPS Diluted: |
0.08 GBP |
- |
Revenues per Share: |
1.10 GBP |
24.44% |
Book Value per Share: |
1.41 GBP |
35.58% |
Cash Flow per Share: |
0.04 GBP |
- |
Dividend per Share: |
0.00 GBP |
- |
Total |
in mill. |
|
Revenues: |
87.70 GBP |
36.82% |
Net Income: |
-6.20 GBP |
-61.49% |
Operating Cash Flow: |
3.10 GBP |
- |
Cash and Cash Equivalents: |
46.70 GBP |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
38.20 |
129.32 |
P/S Ratio: |
2.72 |
9.21 |
P/BV ratio: |
2.12 |
7.16 |
P/CF Ratio: |
76.93 |
260.47 |
PEG: |
- |
- |
Earnings Yield: |
2.62% |
0.77% |
Dividend Yield: |
0.00% |
0.00% |
Market Capitalization |
|
Market Capitalization: |
238.49 mill. GBP |
807.44 mill. GBP |
Free Float Market Cap.: |
119.72 mill. GBP |
405.34 mill. GBP |
Market Cap. / Employee: |
354,362.3493 GBP |
1.2 mill. GBP |
Shares Outstanding: |
79.95 mill. |
|
Profitability
Gross Profit Margin: |
52.57% |
EBIT Margin: |
-6.50% |
Net Profit Margin: |
-7.07% |
Return on Equity: |
-5.50% |
Return on Assets: |
-3.37% |
Financial Strength
Liquidity I / Cash Ratio: |
88.95% |
Liquidity II / Quick Ratio: |
191.62% |
Liquidity III / Current Ratio: |
205.52% |
Debt / Equity Ratio: |
63.18% |
Dynam. Debt / Equity Ratio: |
2,296.77% |
Efficiency
Employees: |
673 |
Personal Expenses / Employee: |
- GBP |
Revenues / Employee: |
130,312.04 GBP |
Net Income / Employee: |
-9,212.48 GBP |
Total Assets / Employee: |
273,254.09 GBP |
* Fiscal Year End: |
2020-12-31 |
Accounting Standard: |
IFRS |